Current status and future directions of gene and cell therapy for cystic fibrosis

BioDrugs

Volumn 25, Issue 2, 2011, Pages 77-88

  Griesenbach, Uta ^a,b,c   Alton, Eric W F W ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UK Cystic Fibrosis Gene Therapy Consortium   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cell therapies, therapeutic use; Cystic fibrosis, treatment; Gene delivery systems; Gene therapies, therapeutic use

Indexed keywords

ADENOVIRUS VECTOR; CARBOXYMETHYLCELLULOSE; LENTIVIRUS VECTOR; PLASMID VECTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CELL THERAPY; GENE TRANSFER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LUNG FIBROSIS; LUNG FUNCTION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; REVIEW; SENDAI VIRUS; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CLINICAL TRIALS AS TOPIC; CYSTIC FIBROSIS; GENE THERAPY; GENETIC VECTORS; HUMANS; TISSUE THERAPY;

EID: 79953215718     PISSN: 11738804     EISSN: 1179190X     Source Type: Journal    
DOI: 10.2165/11586960-000000000-00000     Document Type: Review

References (95)

1. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementaryDNA. Science 1989 Sep 8; 245 (4922): 1066-73 (Pubitemid 19231814)
2. Boucher RC. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 2007; 58: 157-70 (Pubitemid 46706507)
3. Welsh M, Ramsey BW, Accurso F, et al. The molecular and metabolic basis of inherited disease. In: Scriver CR, Beaudet AL, Sly WS, et al., editors. Cystic fibrosis. New York: McGraw-Hill, 2001: 5121-88
4. Sanders N, Rudolph C, Braeckmans K, et al. Extracellular barriers in respiratory gene therapy. Adv Drug Deliv Rev 2009 Feb 27; 61 (2): 115-27
5. Chu CS, Trapnell BC, Curristin S, et al. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 1993 Feb; 3 (2): 151-6 (Pubitemid 23079798)
6. Johnson LG, Olsen JC, Sarkadi B, et al. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet 1992 Sep; 2 (1): 21-5
7. Farmen SL, Karp PH, Ng P, et al. Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR. Am J Physiol Lung Cell Mol Physiol 2005 Dec; 289 (6): L1123-30 (Pubitemid 41681347)
8. Johnson LG, Boyles SE, Wilson J, et al. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirusmediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. J Clin Invest 1995 Mar; 95 (3): 1377-82
9. Pringle IA,Hyde SC, Gill DR. Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects. Expert Opin Biol Ther 2009 Aug; 9 (8): 991-1003
10. Griesenbach U, Alton EW. Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy. Adv Drug Deliv Rev 2009 Feb 27; 61 (2): 128-39
11. Alton EW, Stern M, Farley R, et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 1999 Mar 20; 353 (9157): 947-54 (Pubitemid 29132602)
12. Griesenbach U, McLachlan G, Owaki T, et al. Validation of recombinant Sendai virus in a non-natural host model. Gene Ther. Epub 2010 Oct 21
13. Griesenbach U, Sumner-Jones SG, Holder E, et al. Limitations of the murine nose in the development of nonviral airway gene transfer. Am J Respir Cell Mol Biol 2010 Jul; 43 (1): 46-54
14. Hyde SC, Pringle IA, Abdullah S, et al. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression.Nat Biotechnol 2008 May; 26 (5): 549-51 (Pubitemid 351668040)
15. Xenariou S, Griesenbach U, Ferrari S, et al. Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo. Gene Ther 2006 Nov; 13 (21): 1545-52 (Pubitemid 44567151)
16. Xenariou S, Griesenbach U, Liang HD, et al. Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Ther 2007 May; 14 (9): 768-74 (Pubitemid 46585658)
17. Griesenbach U, Meng C, Farley R, et al. The role of doxorubicin in non-viral gene transfer in the lung. Biomaterials 2009 Apr; 30 (10): 1971-7
18. Griesenbach U, Meng C, Farley R, et al. The use of carboxymethylcellulose gel to increase non-viral gene transfer in mouse airways. Biomaterials 2010 Mar; 31 (9): 2665-72
19. Davies LA, McLachlan G, Sumner-Jones SG, et al. Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes. Mol Ther 2008 Jul; 16 (7): 1283-90 (Pubitemid 351866060)
20. Munkonge FM, Amin V, Hyde SC, et al. Identification and functional characterization of cytoplasmic determinants of plasmid DNA nuclear import. J Biol Chem 2009 Sep 25; 284 (39): 26978-87
21. Mayrhofer P, Schleef M, Jechlinger W. Use of minicircle plasmids for gene therapy. Methods Mol Biol 2009; 542: 87-104
22. Gill DR, Pringle IA, Hyde SC. Progress and prospects: the design and production of plasmid vectors. Gene Ther 2009 Feb; 16 (2): 165-71
23. Schuettrumpf J, Milanov P, Abriss D, et al. Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX. Hum Gene Ther 2011 Jan; 22 (1): 101-6
24. Schleef M, Blaesen M. Production of plasmid DNA as a pharmaceutical. Methods Mol Biol 2009; 542: 471-95
25. Zabner J, Couture LA, Gregory RJ, et al. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993 Oct 22; 75 (2): 207-16 (Pubitemid 23320285)
26. Griesenbach U, Inoue M, Hasegawa M, et al. Viral vectors for cystic fibrosis gene therapy: what does the future hold? Virus Adaptation and Treatment 2010 Dec; 2: 159-71
27. Koehler DR, Sajjan U, Chow YH, et al. Protection of CFTR knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing CFTR in airway epithelia. Proc Natl Acad Sci U S A 2003 Dec 23; 100 (26): 15364-9 (Pubitemid 38020995)
28. van Heeckeren AM, Scaria A, Schluchter MD, et al. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection.AmJ Physiol Lung Cell Mol Physiol 2004 Apr; 286 (4): L717-26 (Pubitemid 38365056)
29. Buckley SM, Waddington SN, Jezzard S, et al. Intra-amniotic delivery of CFTR-expressing adenovirus does not reverse cystic fibrosis phenotype in inbred CFTR-knockout mice. Mol Ther 2008 May; 16 (5): 819-24 (Pubitemid 351587089)
30. Davies LA, Varathalingam A, Painter H, et al. Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice. Mol Ther 2008 May; 16 (5): 812-8 (Pubitemid 351587088)
31. Gao G, Vandenberghe LH, Wilson JM. New recombinant serotypes of AAV vectors. Curr Gene Ther 2005 Jun; 5 (3): 285-97 (Pubitemid 40895013)
32. Limberis MP, Vandenberghe LH, Zhang L, et al. Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol Ther 2009 Feb; 17 (2): 294-301
33. Moss RB, Rodman D, Spencer LT, et al. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, doubleblind, placebo-controlled trial. Chest 2004 Feb; 125 (2): 509-21 (Pubitemid 38223630)
34. Moss RB, Milla C, Colombo J, et al. Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial. Hum Gene Ther 2007 Aug; 18 (8): 726-32
35. Wagner JA, Messner AH, Moran ML, et al. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus. Laryngoscope 1999 Feb; 109 (2 Pt 1): 266-74 (Pubitemid 29075570)
36. Aitken ML, Moss RB, Waltz DA, et al. A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum Gene Ther 2001 Oct 10; 12 (15): 1907-16 (Pubitemid 32947233)
37. Wagner JA, Nepomuceno IB, Messner AH, et al. A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum Gene Ther 2002 Jul 20; 13 (11): 1349-59 (Pubitemid 35034514)
38. Flotte TR, Zeitlin PL, Reynolds TC, et al. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum Gene Ther 2003 Jul 20; 14 (11): 1079-88 (Pubitemid 36851399)
39. Beck SE, Jones LA, Chesnut K, et al. Repeated delivery of adeno-associated virus vectors to the rabbit airway. J Virol 1999 Nov; 73 (11): 9446-55 (Pubitemid 29487100)
40. Halbert CL, Standaert TA, Aitken ML, et al. Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J Virol 1997 Aug; 71 (8): 5932-41 (Pubitemid 27304930)
41. Halbert CL, Rutledge EA, Allen JM, et al. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J Virol 2000 Feb; 74 (3): 1524-32 (Pubitemid 30044103)
42. Auricchio A, O'Connor E, Weiner D, et al. Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. J Clin Invest 2002 Aug; 110 (4): 499-504 (Pubitemid 34919704)
43. Fischer AC, Beck SE, Smith CI, et al. Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesusmacaques. Mol Ther 2003 Dec; 8 (6): 918-26 (Pubitemid 38072304)
44. Halbert CL, Madtes DK, Vaughan AE, et al. Expression of human alpha1- antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs. Mol Ther 2010 Jun; 18 (6): 1165-72
45. Liu X, Luo M, Guo C, et al. Analysis of adeno-associated virus progenitor cell transduction in mouse lung. Mol Ther 2009 Feb; 17 (2): 285-93
46. Ferrari S, Griesenbach U, Shiraki-Iida T, et al. A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo. Gene Ther 2004 Nov; 11 (22): 1659-64 (Pubitemid 39530102)
47. Zhang L, Bukreyev A, Thompson CI, et al. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol 2005 Jan; 79 (2): 1113-24 (Pubitemid 40053894)
48. Zhang L, Button B, Gabriel SE, et al. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium. PLoS Biol 2009 Jul; 7 (7): e1000155
49. Kwilas AR, Yednak MA, Zhang L, et al. Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro. J Virol 2010 Aug; 84 (15): 7770-81
50. Okada Y. Sendai virus-induced cell fusion. Methods Enzymol 1993; 221: 18-41 (Pubitemid 23264575)
51. Ferrari S, Griesenbach U, Iida A, et al. Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther 2007 Oct; 14 (19): 1371-9 (Pubitemid 47423736)
52. Inoue M, Tokusumi Y, Ban H, et al. Nontransmissible virus-like particle formation by F-deficient Sendai virus is temperature sensitive and reduced by mutations in M and HN proteins. J Virol 2003 Mar; 77 (5): 3238-46 (Pubitemid 36228107)
53. Griesenbach U, Boyton RJ, Somerton L, et al. Effect of tolerance induction to immunodominant T-cell epitopes of Sendai virus on gene expression following repeat administration to lung. Gene Ther 2006 Mar; 13 (5): 449-56
54. Kobayashi M, Iida A, Ueda Y, et al. Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus. J Virol 2003 Feb; 77 (4): 2607-14 (Pubitemid 36222785)
55. Mitomo K, Griesenbach U, Inoue M, et al. Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes. Mol Ther 2010 Mar 23; 18 (6): 1173-82
56. Sinn PL, Arias AC, Brogden KA, et al. Lentivirus vector can be readministered to nasal epithelia without blocking immune responses. J Virol 2008 Nov; 82 (21): 10684-92 (Pubitemid 352691165)
57. McKay T, Patel M, Pickles RJ, et al. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors. Gene Ther 2006 Apr; 13 (8): 715-24
58. Limberis M, Anson DS, Fuller M, et al. Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer.HumGeneTher 2002Nov 1; 13 (16): 1961-70 (Pubitemid 35341037)
59. Cmielewski P, Anson DS, Parsons DW. Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain length. Respir Res 2010 Jun 23; 11 (1): 84-95
60. Medina MF, Kobinger GP, Rux J, et al. Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Mol Ther 2003 Nov; 8 (5): 777-89 (Pubitemid 37527453)
61. Stocker AG, Kremer KL, Koldej R, et al. Single-dose lentiviral gene transfer for lifetime airway gene expression. J Gene Med 2009 Oct; 11 (10): 861-7
62. Rawlins EL, Hogan BL. Ciliated epithelial cell lifespan in the mouse trachea and lung. Am J Physiol Lung Cell Mol Physiol 2008 Jul; 295 (1): L231-4
63. Howe SJ, Mansour MR, Schwarzwaelder K, et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 2008 Sep; 118 (9): 3143-50
64. Zufferey R, Dull T,Mandel RJ, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998 Dec; 72 (12): 9873-80 (Pubitemid 28520853)
65. Montini E, Cesana D, Schmidt M, et al. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest 2009 Apr; 119 (4): 964-75
66. Buckley SM, Howe SJ, Sheard V, et al. Lentiviral transduction of the murine lung provides efficient pseudotype and developmental stage-dependent cellspecific transgene expression. Gene Ther 2008 Aug; 15 (16): 1167-75
67. Mishra S, Wang X, Smiley N, et al. Genetic modification of airway progenitors following lentiviral gene delivery to the amniotic fluid of murine fetuses.AmJ Respir Cell Mol Biol. Epub 2010 Jun 25
68. Wilson AA, Murphy GJ, Hamakawa H, et al. Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages. J Clin Invest 2010 Jan 4; 120 (1): 379-89
69. Griese M, Latzin P, Kappler M, et al. Alpha1-antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. Eur Respir J 2007 Feb; 29 (2): 240-50 (Pubitemid 46231900)
70. Huang HY, Lee CC, Chiang BL. Short hairpin RNAs against eotaxin or interleukin-5 decrease airway eosinophilia and hyper-responsiveness in a murine model of asthma. J Gene Med 2009 Feb; 11 (2): 112-8
71. Scherr M, Venturini L, Eder M. Lentiviral vector-mediated expression of premiRNAs and antagomiRs. Methods Mol Biol 2010; 614: 175-85
72. Weiss DJ. Stem cells and cell therapies for cystic fibrosis and other lung diseases. Pulm Pharmacol Ther 2008 Aug; 21 (4): 588-94 (Pubitemid 351970708)
73. Wong AP, Keating A, Lu WY, et al. Identification of a bone marrow-derived epithelial-like population capable of repopulating injured mouse airway epithelium. J Clin Invest 2009 Feb; 119 (2): 336-48
74. Wang G, Bunnell BA, Painter RG, et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci U S A 2005 Jan 4; 102 (1): 186-91 (Pubitemid 40094450)
75. Kotton DN, Fine A. Lung stem cells. Cell Tissue Res 2008 Jan; 331 (1): 145-56 (Pubitemid 350265489)
76. Bruscia EM, Price JE, Cheng EC, et al. Assessment of cystic fibrosis transmembrane conductance regulator (CFTR) activity in CFTR-null mice after bone marrow transplantation. ProcNatl Acad SciUSA 2006 Feb 21; 103 (8): 2965-70
77. Bruscia EM, Ziegler EC, Price JE, et al. Engraftment of donor-derived epithelial cells in multiple organs following bone marrow transplantation into newborn mice. Stem Cells 2006 Oct; 24 (10): 2299-308 (Pubitemid 44527484)
78. Loi R, Beckett T, Goncz KK, et al. Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Am J Respir Crit Care Med 2006 Jan 15; 173 (2): 171-9 (Pubitemid 43187889)
79. Rejman J, Colombo C, Conese M. Engraftment of bone marrow-derived stem cells to the lung in a model of acute respiratory infection by Pseudomonas aeruginosa. Mol Ther 2009 Jul; 17 (7): 1257-65
80. Duchesneau P, Wong AP, Waddell TK. Optimization of targeted cell replacement therapy: a new approach for lung disease. Mol Ther 2010 Oct; 18 (10): 1830-6
81. Lin YM, ZhangA, Bismarck A, et al. Effects of fibroblast growth factors on the differentiation of the pulmonary progenitors from murine embryonic stem cells. Exp Lung Res 2010 Jun; 36 (5): 307-20
82. Samadikuchaksaraei A, Cohen S, Isaac K, et al. Derivation of distal airway epithelium from human embryonic stem cells. Tissue Eng 2006 Apr; 12 (4): 867-75 (Pubitemid 43726528)
83. Rippon HJ, Lane S, Qin M, et al. Embryonic stem cells as a source of pulmonary epithelium in vitro and in vivo. Proc Am Thorac Soc 2008 Aug 15; 5 (6): 717-22
84. Leblond AL, Naud P, Forest V, et al. Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury. Hum Gene Ther 2009 Nov; 20 (11): 1329-43
85. Wang D, Morales JE, CalameDG, et al. Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther 2010 Mar; 18 (3): 625-34
86. Pickering SJ, Minger SL, Patel M, et al. Generation of a human embryonic stem cell line encoding the cystic fibrosis mutation deltaF508, using preimplantation genetic diagnosis. Reprod Biomed Online 2005 Mar; 10 (3): 390-7 (Pubitemid 40372676)
87. Somers A, Jean JC, Sommer CA, et al. Generation of transgene-free lung disease-specific human iPS cells using a single excisable lentiviral stem cell cassette. Stem Cells 2010 Oct; 28 (10): 1728-40
88. Wang XX, Zhang FR, Shang YP, et al. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol 2007 Apr 10; 49 (14): 1566-71
89. Weiss DJ, Finck C. Embryonic stem cells and repair of lung injury. Mol Ther 2010 Mar; 18 (3): 460-1
90. Macchiarini P, Jungebluth P, Go T, et al. Clinical transplantation of a tissueengineered airway. Lancet 2008 Dec 13; 372 (9655): 2023-30
91. Petersen TH, Calle EA, Zhao L, et al. Tissue-engineered lungs for in vivo implantation. Science 2010 Jul 30; 329 (5991): 538-41
92. Stoltz DA, Meyerholz DK, Pezzulo AA, et al. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med 2010 Apr 28; 2 (29): 29ra31
93. Sun X, Yan Z, Yi Y, et al. Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets. J Clin Invest 2008 Apr; 118 (4): 1578-83 (Pubitemid 351500451)
94. Que C, Cullinan P, Geddes D. Improving rate of decline of FEV1 in young adults with cystic fibrosis. Thorax 2006 Feb; 61 (2): 155-7 (Pubitemid 43235433)
95. Grasemann H, Ratjen F. Emerging therapies for cystic fibrosis lung disease. Expert Opin Emerg Drugs 2010 Dec; 15 (4): 653-9